Q4 2024 Holdings
Filed 2025-02-13 | 67 holdings | $352.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $23.9M | 1,395,000 | 6.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $18.3M | 432,000 | 5.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.4M | 127,000 | 4.4% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $15.4M | 1,850,000 | 4.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $14.1M | 305,000 | 4.0% |
| Establishment Labs Hldgs Inc(ESTA)Call | COM | G31249108 | $13.8M | 300,000 | 3.9% |
| Scholar Rock Hldg Corp(SRRK)Call | COM | 80706P103 | $13.0M | 300,000 | 3.7% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $12.2M | 165,000 | 3.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.3M | 288,000 | 3.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $11.2M | 250,000 | 3.2% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $9.9M | 714,000 | 2.8% |
| Rxsight Inc(RXST) | COM | 78349D107 | $9.8M | 285,000 | 2.8% |
| Merit MED SYS Inc(MMSI) | COM | 589889104 | $9.7M | 100,000 | 2.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $9.3M | 250,000 | 2.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $9.1M | 132,000 | 2.6% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.3M | 1,694,000 | 2.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $7.6M | 685,000 | 2.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $6.3M | 75,000 | 1.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $6.2M | 10,000 | 1.7% |
| Glaukos Corp(GKOS) | COM | 377322102 | $6.0M | 40,000 | 1.7% |
| Resmed Inc(RMD) | COM | 761152107 | $5.9M | 26,000 | 1.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.9M | 146,000 | 1.7% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $5.6M | 100,000 | 1.6% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $5.5M | 815,000 | 1.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.4M | 1,424,400 | 1.5% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $5.3M | 255,000 | 1.5% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $4.9M | 334,000 | 1.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.9M | 370,000 | 1.4% |
| Savara Inc(SVRA) | COM | 805111101 | $4.8M | 1,579,000 | 1.4% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $4.8M | 452,475 | 1.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $4.5M | 385,000 | 1.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $4.3M | 230,257 | 1.2% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $4.1M | 737,000 | 1.2% |
| Profound MED Corp(PROF) | COM NEW | 74319B502 | $3.6M | 485,000 | 1.0% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $3.3M | 7,415,413 | 0.9% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $3.2M | 1,139,000 | 0.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.9M | 355,000 | 0.8% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.9M | 95,000 | 0.8% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $2.8M | 3,000,000 | 0.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $2.8M | 175,000 | 0.8% |
| Anaptysbio Inc(ANAB)Put | COM | 032724106 | $2.7M | 206,200 | 0.8% |
| Immunitybio Inc(IBRX) | COM | 45256X103 | $2.7M | 1,060,000 | 0.8% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $2.7M | 405,000 | 0.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.6M | 475,000 | 0.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.6M | 60,000 | 0.7% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.6M | 1,428,000 | 0.7% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $2.4M | 264,562 | 0.7% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $2.0M | 505,000 | 0.6% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $1.9M | 218,386 | 0.5% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $1.6M | 275,000 | 0.5% |